Oförändrat svår marknad, men den har inte blivit sämre Med en telekommarknad som har lägre investeri...
Today, Advenica recieved its third order for this quarter of SEK8.
Svag marknad över flera geografier Adtraction minskade omsättningen med 0,7 procent i det första kva...
Redeye provides a note following NeoDynamics’ Q1 2024 report.
Redeye states that InfraCom's net sales was below expectations, and InfraCom states a tougher macro-...
Redeye views the Q1 report as a confirmation of the progress made with the first sales of Terclara i...
Redeye saw a sales development that was better than our expectations.
Administer’s Q1 net sales declined by 3.1% y/y, driven by a 14.
Aspo’s Q1 EBIT was soft relative to estimates, yet markets have now mostly stabilized; all three seg...
With a striking renegotiation of the final purchase agreement for Sydvaranger, reducing the initial ...
Performance Chemicals grows 17% as EBIT nears breakeven Cost-savings programme successful, but still...
With a new THC/CBD medical cannabis oil approved, which is ready for sales under the Danish pilot pr...
The McQuade Center for Strategic Research and Development (MSRD) has signed an exclusive R&D collabo...
Net sales were 12% above consensus (LSEG) in Q1. Revenue decreased by 29% y/y in Q1 but grew by 38% ...
Recorded sales improved to SEK 17.9m (10.9m in Q4 and SEK 0m in Q1 2023), and the cash balance was ...
Stabilt kvartal trots avsaknad av projektförsäljningar och låga intäkter från Lebo Arise levererade ...
Relais reported Q1 adjusted EBITA of EUR 9.7m, 13% above LSEG Data & Analytics consensus.
Redeye comments on Fantasma Games’ Q1 results, which came in better than expected both in terms of s...
Investors House reported Q1 revenues of EUR 1.6m, 4% below our 1.
